1. Home
  2. ARL vs TTRX Comparison

ARL vs TTRX Comparison

Compare ARL & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Realty Investors Inc.

ARL

American Realty Investors Inc.

N/A

Current Price

$16.72

Market Cap

256.7M

Sector

Real Estate

ML Signal

N/A

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$13.52

Market Cap

298.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARL
TTRX
Founded
1999
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
256.7M
298.8M
IPO Year
1999
2025

Fundamental Metrics

Financial Performance
Metric
ARL
TTRX
Price
$16.72
$13.52
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $25.00
AVG Volume (30 Days)
4.0K
★ 131.5K
Earning Date
11-05-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 206.59
N/A
EPS
★ N/A
N/A
Revenue
★ $50,014,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$900.00
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 5.70
N/A
52 Week Low
$12.42
$2.57
52 Week High
$24.44
$16.45

Technical Indicators

Market Signals
Indicator
ARL
TTRX
Relative Strength Index (RSI) 52.90 61.03
Support Level $14.45 $3.80
Resistance Level $16.91 $14.39
Average True Range (ATR) 0.60 1.31
MACD 0.06 -0.11
Stochastic Oscillator 71.04 49.83

Price Performance

Historical Comparison
ARL
TTRX

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments: the acquisition, development, ownership and management of multifamily properties (Residential Segment) and the acquisition, ownership and management of commercial real estate properties (Commercial Segment). Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: